Skip to main content
. 2023 Jan 20;41(7):1303–1309. doi: 10.1016/j.vaccine.2023.01.036

Table 1.

Characteristics of the selected studies included in meta-analysis and systematic review.

First author Year Quality Hesitant patients (n) Total sample Study period Country
Tsai R [16]§ 2022 h 266 1400 January–February 2021 more countries
Wang Y [17] 2022 h 273 483 April–August 2021 China
Aldossari KK [18] 2021 h 200 709 March–May 2021 Saudi Arabia
Asadi-Pooya AA [19]*,§ 2021 m 2 127 late 2020 Iran
Guaraldi F [20] 2021 h 185 1176 January 2021 Italy
Nachimuthu S [21]** 2021 m 133 179 March–April 2021 India
Scoccimaro D [22]* 2021 m 92 502 January–April 2021 Italy
*

Short report.

**

Letter to editor.

§

Not included in systematic review.